LINC00963 facilitated NOP2 by sponging the cancer inhibitor miR-542-3p to promote prostate cancer metastasis, where NOP2 promoted prostate cancer invasion by activating the epithelial–mesenchymal transition (EMT) pathway [106]. The gene discussed is NOP2; the disease is prostate carcinoma.